US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

14.12

+0.35002.54%

Post-market: 14.120.00000.00%19:30 EDT

Volume:1.11M

Turnover:15.33M

Market Cap:898.00M

PE:-6.03

High:14.17

Open:13.86

Low:13.31

Close:13.77

52wk High:28.00

52wk Low:8.16

Shares:63.60M

Float Shares:47.12M

Volume Ratio:1.48

T/O Rate:2.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.31

PE(LYR):-4.42

Loading ...

Overview Company News Filings

BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201

Jade Biosciences doses first participant in Phase 1 trial of autoimmune drug candidate JADE201

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of Jade201, a Novel Half-Life Extended Afucosylated Anti-Baff Receptor Monoclonal Antibody

THOMSON REUTERS

Jade Biosciences Doses First Patient in Phase 2 Study of Kidney Disease Therapy

MT Newswires Live

Jade Biosciences Announces First Participant Dosed in Phase 2 Juniper Clinical Trial of Jade101 in Iga Nephropathy

THOMSON REUTERS

Jade Biosciences Inc - Interim Data From Juniper Phase 2 Trial Expected in 2027

THOMSON REUTERS

BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing

Jade Biosciences price target raised to $34 from $24 at Wedbush

Jade Biosciences Is Maintained at Outperform by Wedbush

Jade Biosciences Inc : Guggenheim Raises Target Price to $32 From $23

THOMSON REUTERS

Stock Track | Jade Biosciences Soars 5.45% Intraday on Analyst Price Target Hikes and Upcoming Pipeline Catalysts

Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target

Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating

MT Newswires Live

Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach

Jade Biosciences files $600M mixed securities shelf

BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing

Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing

THOMSON REUTERS

Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate

Benzinga Earnings

Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/JBIO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":14.12,"timestamp":1790971200000,"preClose":13.77,"halted":0,"volume":1109845,"hourTrading":{"tag":"盘后","latestPrice":14.12,"preClose":14.12,"latestTime":"19:30 EDT","volume":23631,"amount":333685.12,"timestamp":1790983803180,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.025417574437182254,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Closed","change":0.35,"latestTime":"10-02 16:00:00 EDT","open":13.86,"high":14.17,"low":13.31,"amount":15334121.279785,"amplitude":0.062455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":5,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":13.77,"preHourTrading":{"tag":"盘前","latestPrice":13.88,"preClose":13.77,"latestTime":"09:29 EDT","volume":228,"amount":3162.818052,"timestamp":1790947799999,"change":0.11,"changeRate":0.007988,"amplitude":0.145243},"postHourTrading":{"tag":"盘后","latestPrice":14.12,"preClose":14.12,"latestTime":"19:30 EDT","volume":23631,"amount":333685.12,"timestamp":1790983803180,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.477152,"impliedVol":1.1016,"impliedVolPercentile":0.7849},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.477152,"shares":63597387,"dividePrice":0,"high":14.17,"amplitude":0.062455,"preClose":13.77,"low":13.31,"week52Low":8.16,"pbRate":"0.31","week52High":28,"institutionHeld":0,"latestPrice":14.12,"eps":-2.343303,"divideRate":0,"volume":1109845,"delay":0,"ttmEps":-2.343303,"open":13.86,"prevYearClose":15.43,"prevWeekClose":14.42,"prevMonthClose":14.05,"prevQuarterClose":14.05,"fiveDayClose":14.42,"twentyDayClose":19.85,"sixtyDayClose":22.48,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-10-01","current":-5.893391,"percent":0.563218,"low":-10.392766,"twenty":-8.786661,"median":-6.448364,"eighty":-2.874869,"high":-2.319279,"avg":-5.945451,"sd":2.630204,"marketCap":893543287},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369},{"date":"2026-09-04","current":-8.238111,"twenty":-8.852338,"median":-6.276995,"eighty":-2.844205,"marketCap":1262408131},{"date":"2026-09-11","current":-7.943448,"twenty":-8.846064,"median":-6.423883,"eighty":-2.855122,"marketCap":1217253987},{"date":"2026-09-18","current":-7.113412,"twenty":-8.837489,"median":-6.471481,"eighty":-2.857913,"marketCap":1090059213},{"date":"2026-09-25","current":-6.113218,"twenty":-8.815816,"median":-6.487254,"eighty":-2.866667,"marketCap":936789510},{"date":"2026-10-01","current":-5.831006,"twenty":-8.786661,"median":-6.448364,"eighty":-2.874869,"marketCap":893543287}],"updateTime":1790959079867},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638154098","title":"BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201","url":"https://stock-news.laohu8.com/highlight/detail?id=2638154098","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638154098?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:09","pubTimestamp":1779826164,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Announces First Participant Dosed In First-In-Human Phase 1 Clinical Trial Of Jade201May 26 (Reuters) - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES ANNOUNCES FIRST PARTICIPANT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA3GRWRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540935","title":"Jade Biosciences doses first participant in Phase 1 trial of autoimmune drug candidate JADE201","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540935?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:09","pubTimestamp":1779826141,"startTime":"0","endTime":"0","summary":"Jade Biosciences dosed the first participant in a first-in-human Phase 1 trial of JADE201 in rheumatoid arthritis.Interim Phase 1 results have not been presented; readouts are expected in 2027.The study will evaluate whether JADE201 can show an acceptable safety profile with evidence of the intended B-cell effects.The 2027 data are expected to guide which autoimmune indications move forward, shaping portfolio focus and development spending.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLx1Jx8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","BK4139","BK4588","IE00BN0W2W23.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4539","BK4112","IE00B3QW5Z07.USD","JBIO","LU2210149790.SGD","BK4585","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638512540","title":"Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of Jade201, a Novel Half-Life Extended Afucosylated Anti-Baff Receptor Monoclonal Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2638512540","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638512540?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:05","pubTimestamp":1779825900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA3GRWRN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638511831","title":"Jade Biosciences Doses First Patient in Phase 2 Study of Kidney Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638511831","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638511831?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:36","pubTimestamp":1779795404,"startTime":"0","endTime":"0","summary":"Jade Biosciences  has dosed the first participant in its phase 2 trial of experimental therapy, JADE101, for immunoglobulin A nephropathy, or IgAN, the drugmaker said Tuesday.IgAN is a chronic autoimmune kidney disease that can progress to kidney failure over time, often affecting younger patients.The open-label study will enroll about 30 participants and evaluate safety, tolerability, kidney function and protein levels in urine as markers of disease progression, the company said.Interim results are expected in 2027, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516994","title":"Jade Biosciences Announces First Participant Dosed in Phase 2 Juniper Clinical Trial of Jade101 in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516994?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA5JJSVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638162595","title":"Jade Biosciences Inc - Interim Data From Juniper Phase 2 Trial Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2638162595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638162595?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA5JJSVZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058494","title":"BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058494","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058494?lang=en_us&edition=fundamental","pubTime":"2026-05-16 05:04","pubTimestamp":1778879043,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Inc - Prospectus Filed For Resale Of Up To 39,542,339 Shares By Selling Stockholders - SEC FilingMay 15  - Jade Biosciences Inc JBIO.O:JADE BIOSCIENCES INC - PROSPECTUS FILED FOR RESALE OF UP TO 39,542,339 SHARES BY SELLING STOCKHOLDERS - SEC FILINGSource text: [ID:n0001193125-26-227051]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634239643","title":"Jade Biosciences price target raised to $34 from $24 at Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634239643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634239643?lang=en_us&edition=fundamental","pubTime":"2026-05-12 01:25","pubTimestamp":1778520316,"startTime":"0","endTime":"0","summary":"Wedbush analyst Laura Chico raised the firm’s price target on Jade Biosciences (JBIO) to $34 from $24 and keeps an Outperform rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-34-from-24-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-34-from-24-at-wedbush-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228974","title":"Jade Biosciences Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228974","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634228974?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:31","pubTimestamp":1778502660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 08:31 ET (12:31 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634479578","title":"Jade Biosciences Inc : Guggenheim Raises Target Price to $32 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2634479578","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634479578?lang=en_us&edition=fundamental","pubTime":"2026-05-11 12:02","pubTimestamp":1778472173,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41L1TU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120340917","title":"Stock Track | Jade Biosciences Soars 5.45% Intraday on Analyst Price Target Hikes and Upcoming Pipeline Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1120340917","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120340917?lang=en_us&edition=fundamental","pubTime":"2026-05-08 22:12","pubTimestamp":1778249523,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) stock soared 5.45% during intraday trading on Friday, following a series of positive analyst actions and outlooks for the company's pipeline.The surge comes after Wedbush...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633445293","title":"Jade Biosciences: Buy Rating Reiterated on Strong Cash Runway, JADE101 Differentiation, and Unchanged $24 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2633445293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633445293?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:55","pubTimestamp":1778248525,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Jade Biosciences today and set a price target of $24.00. Rami Katkhuda has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/jade-biosciences-buy-rating-reiterated-on-strong-cash-runway-jade101-differentiation-and-unchanged-24-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633245661","title":"Wedbush Raises Price Target on Jade Biosciences to $34 From $24, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2633245661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633245661?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:22","pubTimestamp":1778242942,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) has an average rating of Buy and mean price target of $24.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431524","title":"Analyst Reiterates Buy on Jade Biosciences as JADE101 Data and Multi-Asset Pipeline Catalysts Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633431524?lang=en_us&edition=fundamental","pubTime":"2026-05-08 17:36","pubTimestamp":1778232985,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on JBIO stock, giving a Buy rating today. Matt Phipps has given his Buy ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-jade-biosciences-as-jade101-data-and-multi-asset-pipeline-catalysts-approach-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633058151","title":"Jade Biosciences files $600M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2633058151","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633058151?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:32","pubTimestamp":1778193132,"startTime":"0","endTime":"0","summary":"17:17 EDT Jade Biosciences (JBIO) files $600M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-files-600m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633103496","title":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103496","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633103496?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:27","pubTimestamp":1778192858,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC FilingMay 7  - SEC Filing: JADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $600 MILLION OF SECURITIES - SEC FILINGJADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $200 MILLION COMMON STOCK UNDER SALES AGREEMENT WITH JEFFERIES - SEC FILINGSource text: [ID:n0001193125-26-212422]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170901","title":"Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock  by the Selling Stockholders  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170901?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:21","pubTimestamp":1778188898,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170548","title":"Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170548?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:15","pubTimestamp":1778188553,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174738","title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174738","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174738?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:35","pubTimestamp":1778186138,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.51) by 11.76 percent. This is a 95.29 percent increase over losses of $(12.10) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52392153/jade-biosciences-q1-eps-0-57-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633637174","title":"Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633637174","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633637174?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:29","pubTimestamp":1778185782,"startTime":"0","endTime":"0","summary":"Jade Biosciences posted a Q1 net loss of $40.4 million, compared with a $38.2 million loss a year earlier.R&D expense climbed to $36.1 million from $20 million, while G&A costs rose to $7.4 million from $3.4 million.Cash, cash equivalents, investments totaled $311.3 million as of March 31, with runway expected into first-half 2028.Phase 2 trial of lead IgA nephropathy candidate JADE101 expected to start in Q2, with interim data expected in 2027; interim biomarker-rich Phase 1 data set for an oral presentation at the European Renal Association Congress.Phase 1 study of JADE201 in rheumatoid arthritis expected to begin in Q2 with interim data expected in 2027, while JADE301 first-in-human trial remains on track for first-half 2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbq1Hkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SG9999014013.SGD","BK4588","JBIO","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","IE00BKPKM429.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00B64PRP62.GBP","BK4139","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","BK4112","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":116,"code":"91000000","status":"200"}]}}